Steven Smith, MD
Otolaryngology · Columbus, MSNPI 1376804369
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,514 of the $2,231 with a category attached, or 67.8%. Medical Device Business Services, Inc. accounts for 70.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $1,741 and has fallen 98.2% since, to $31 in 2025.
Across 23 payments — averaging $97.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$2K
- Acclarent, Inc$330
- Inspire Medical Systems, Inc.$91
- Medtronic$58
- Olympus America Inc.$43
- Intersect ENT, Inc.$34
- plus $103 from 5 others
What the payments were for
- Travel & lodging$1,51468%
- Food & beverage$71832%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 4 | $1,570 |
| Acclarent, Inc | 5 | $330 |
| Inspire Medical Systems, Inc. | 1 | $91 |
| Medtronic(2 entities) | 2 | $58 |
| Olympus America Inc. | 3 | $43 |
| Intersect ENT, Inc. | 2 | $34 |
| GSK | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Sanofi | 1 | $20 |
| Merck | 1 | $16 |
| Stryker | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,231 in reported general payments places this provider in the 70th percentile of 97 otolaryngology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 111 | $2,690 |
| Epinephrine | 14 | $2,027 |
| Levocetirizine Dihydrochloride | 100 | $1,205 |
| Fluticasone Propionate | 113 | $890 |
| Montelukast Sodium | 175 | $888 |
| Azelastine Hcl | 47 | $739 |
| Famotidine | 122 | $690 |
| Fluocinolone Acetonide Oil | 19 | $615 |
| Ofloxacin | 14 | $498 |
| Mometasone Furoate | 11 | $371 |
| Pantoprazole Sodium | 61 | $259 |
| Mupirocin | 28 | $222 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 18 | $204 |
| Methylprednisolone | 37 | $198 |
| Omeprazole | 38 | $147 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Columbus
- Robert BordenColumbus$677
- Raymond WeissOcean Springs$258K
- Robert YarberTupelo$7K
- Charles WilsonOcean Springs$7K
- Gregory PippinMcComb$6K
- Savannah StocktonBrookhaven$6K
- John SchweinfurthJackson$6K
- Jess RobertsJackson$5K
- Byron WindhamOxford$5K
- Thomas EbyJackson$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.